Glaucoma occurs when fluid in the eye cannot drain properly, leading to increased intraocular pressure (IOP), which can damage the optic nerve and cause vision loss. And therefore, this smallest medical device, the iStent inject Trabecular Micro-Bypass is known to be implanted in the body. It measures 0.36mm and is made of titanium. It is designed to help manage primary open-angle glaucoma, pseudoexfoliative glaucoma and pigmentary glaucoma by improving fluid drainage in the eye.
The iStent inject works by creating a bypass through the trabecular meshwork, the primary blockage site. It improves the eye's natural fluid outflow, and reduces the pressure. It works continuously to keep fluid draining properly.
The iStent inject offers a variety of benefits over traditional glaucoma treatments. Many patients experience a reduced need for glaucoma eye drops, lowering costs and minimizing potential side effects. The procedure is made to be gentle and low-impact, preserving the eye’s natural anatomy while reducing tissue disruption for a safer, and more comfortable experience.
Its versatile placement allows it to be implanted during cataract surgery or as a standalone procedure, making it a flexible option for patients at different stages of treatment. Recovery is typically quick, with most patients returning to daily activities sooner. Studies show that 72% of patients no longer needed glaucoma medication after receiving iStent inject, highlighting its proven effectiveness.
The iStent inject Trabecular Micro-Bypass System is a minimally invasive treatment designed to lower intraocular pressure (IOP) in patients with glaucoma. Unlike traditional glaucoma surgeries, it is implanted through a small, self-sealing incision in the cornea, preserving the natural structure of the eye. This approach reduces the risk of complications while offering an effective and long-term solution for managing glaucoma.
By creating a permanent bypass in the trabecular meshwork, the iStent inject continuously enhances the eye’s natural fluid outflow. This helps reduce intraocular pressure safely and effectively, lowering the risk of optic nerve damage and vision loss over time. An international study found that 72% of patients treated with iStent inject no longer needed glaucoma medication after 12 months, highlighting its lasting impact.
The iStent inject procedure is typically performed as a day case, allowing patients to return home the same day. While some blurriness and redness may occur for a few days, most patients experience a smooth and quick recovery. The procedure not only helps control glaucoma but may also contribute to improved vision when combined with cataract surgery, offering a comprehensive solution for those with both conditions.
iStent inject can be implanted during cataract surgery or as a standalone procedure. This dual compatibility makes it an excellent choice for patients undergoing cataract surgery who also need glaucoma treatment. By combining both procedures, patients can effectively manage eye pressure while addressing vision clarity in a single surgical session, reducing the need for multiple interventions.
The iStent inject is implanted through a small, self-sealing incision in the cornea, either during cataract surgery or as a standalone procedure. Using a specialized injector, the device is placed in the eye’s natural drainage pathway, improving fluid outflow and lowering intraocular pressure (IOP). The procedure is performed under local anesthesia, so the patient remains awake but feels no discomfort. Once implanted, the iStent inject begins working immediately to help regulate eye pressure.
Glaucoma occurs when fluid cannot drain properly, causing increased pressure that damages the optic nerve. The iStent inject bypasses the trabecular meshwork, the main site of fluid blockage, allowing better drainage into Schlemm’s canal. By enhancing the eye’s natural outflow system, the device reduces intraocular pressure continuously, lowering the risk of vision loss. Unlike medications, which require regular use, iStent inject provides a long-term solution by addressing the root cause of high eye pressure.
The iStent inject is suitable for patients diagnosed with primary open-angle glaucoma, pseudoexfoliative glaucoma, or pigmentary glaucoma. It is beneficial for those who require lower intraocular pressure or seek to reduce dependence on glaucoma medications. Patients with persistent high eye pressure despite prior treatments, including eye drops or conventional surgery, may also be good candidates.
However, the iStent inject is not recommended for individuals with closed-angle glaucoma, glaucoma due to abnormal blood vessel growth, certain eye tumors, or nerve conditions. A consultation with an ophthalmologist is essential to determine if this minimally invasive procedure is the right choice for managing glaucoma effectively.
Glaucoma is primarily caused by increased intraocular pressure (IOP) due to improper drainage of fluid from the eye. This pressure can damage the optic nerve, leading to vision loss. While genetics play a significant role, other causes include eye infections, blunt eye trauma, inflammatory eye conditions, and blocked blood vessels. Risk factors such as older age, high eye pressure, decreased corneal thickness, and sudden changes in eye pressure can also contribute to the development of glaucoma.
In the early stages, open-angle glaucoma often has no noticeable symptoms, making regular eye exams essential for early detection. As the condition progresses, patients may experience loss of peripheral (side) vision, which can lead to tunnel vision if left untreated. In angle-closure glaucoma, symptoms are more sudden and severe, including a rapid rise in eye pressure, severe eye pain, headaches, blurred vision, and nausea. Identifying these signs early can prevent significant vision loss.
Since glaucoma can progress without symptoms, early diagnosis is critical to preserving vision. Regular eye check-ups help detect increased eye pressure and optic nerve damage before major vision loss occurs. If left untreated, glaucoma can lead to total blindness. Treatments like the iStent inject, eye drops, or conventional surgery can help control eye pressure and slow the disease’s progression, protecting long-term vision.
Before undergoing the iStent inject procedure, patients will have a detailed eye examination with an ophthalmologist. This includes measuring intraocular pressure (IOP), assessing optic nerve health, and reviewing medical history to determine suitability. Patients with primary open-angle glaucoma, pseudo-exfoliative glaucoma, or pigmentary glaucoma are typically good candidates. The consultation also includes discussing potential benefits, risks, and whether the procedure will be performed alongside cataract surgery.
The iStent inject is implanted using a minimally invasive technique. The procedure is performed under local anesthesia, meaning the patient remains awake but experiences no pain. A small, self-sealing incision is made in the cornea, and a specialized injector is used to place the iStent inject into the trabecular meshwork, the primary drainage pathway of the eye. This helps increase fluid outflow and lower eye pressure. The procedure is quick, often completed within minutes, and the device begins working immediately.
After the procedure, patients may experience temporary blurry vision and mild redness, which typically resolves within a few days. Antibiotic and anti-inflammatory eye drops will be prescribed to prevent infection and aid healing. Patients should avoid rubbing their eyes and may need to wear a protective shield at night for a few days. Most people can resume normal activities within a short period, but follow-up appointments are necessary to monitor eye pressure and healing progress. In many cases, the iStent inject reduces or eliminates the need for glaucoma medication, improving long-term eye health.
While the iStent inject® is a safe and effective treatment for glaucoma, some patients may experience mild and temporary side effects after the procedure. These can include eye redness, inflammation, mild discomfort, and temporarily blurred vision. In rare cases, complications such as stent obstruction, decreased vision sharpness, or cloudiness may occur. Patients with certain eye conditions, including closed-angle glaucoma or abnormal blood vessel growth, are not suitable for this procedure.
To ensure a smooth recovery, patients should follow all post-operative care instructions provided by their ophthalmologist. This includes using prescribed antibiotic and anti-inflammatory eye drops, avoiding rubbing or pressing on the eye, and attending follow-up appointments to monitor healing and eye pressure. Choosing an experienced eye surgeon and undergoing regular eye check-ups can help minimize risks and ensure the best possible outcome.
At Shree Ramkrishna Netralaya, our team of highly experienced eye specialists is dedicated to providing the best care for glaucoma patients. With extensive expertise in minimally invasive glaucoma surgery, our ophthalmologists ensure precise iStent inject implantation, helping patients achieve long-term eye pressure control and vision preservation.
We utilize the latest and modern technology to offer advanced glaucoma treatments. Our advanced diagnostic tools and modern surgical equipment ensure safe, effective, and minimally invasive procedures for faster recovery and improved patient outcomes.
At Shree Ramkrishna Netralaya, eye hospital we prioritize personalized patient care, offering tailored treatment plans to suit individual needs. From pre-surgery consultation to post-operative follow-ups, our compassionate team provides comprehensive guidance, support, and post-surgical care to ensure the best possible results for every patient.
Our team at Shree Ramkrishna Netralaya includes experienced lasik surgeons and specialists who are experts in Lasik treatment:
Yes, iStent inject is clinically proven to reduce intraocular pressure safely and effectively. Studies have shown it to be a safe and minimally invasive option for glaucoma patients.
The iStent inject procedure is quick and efficient, typically completed within minutes under local anesthesia, either as a standalone surgery or during cataract surgery.
An international study showed that 72% of patients treated with iStent inject no longer needed glaucoma medication after 12 months. However, this varies based on individual cases.
Coverage varies depending on your insurance provider and policy. It is recommended to consult your insurer or hospital for detailed coverage information.
Most patients can resume daily activities within a few days, but temporary blurry vision and mild discomfort may occur. Follow your doctor’s instructions for a smooth recovery.
While Shree Ramkrishna Netralaya is your top choice for eye care in Mumbai, you may also consider our other reputable clinics and hospitals near you.
Address:
201 & 202 Elmer #Plot #563, Central Avenue, Corner of, 11th Rd, Chembur, 400071
Phone: 082917 14838
Timing: Mon-Sat- 10 a.m. To 8 p.m.
Address:
Near Risk Care Hospital, Near Makhamali Talao, LBS Marg, Thane, W, Mumbai, Maharashtra 400601
Phone: 02225441139
Timing: Mon-Sat- 11 a.m. To 8 p.m.
